You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 6, June 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aspirin-Induced Hepatotoxicity and Its Effect on Juvenile Rheumatoid Arthritis

Bram H. Bernstein, MD; Bernhard H. Singsen, MD; Karen Koster King, MD; Virgil Hanson, MD

Am J Dis Child. 1977;131(6):659-663.


Abstract

• Evidence of hepatic disease was sought in 102 children with juvenile rheumatoid arthritis (JRA) who were treated with aspirin. Serum glutamic oxaloacetic transaminase level was elevated (greater than 39 IU/liter) in 59% of the children. The degree and prevalence of SGOT elevations correlated with aspirin dose and serum salicylate level. Nevertheless, increased SGOT values were frequently present in children receiving moderate aspirin doses and having serum salicylate levels less than 25 mg/100 ml. Elevated SGOT values decreased in proportion to the degree of reduction in aspirin dose. The SGOT values above the 100 IU/liter were statistically associated with reduced sedimentation rates. Concomitant improvement in the clinical manifestations of JRA was noted in some children.

(Am J Dis Child 131:659-663, 1977)



Author Affiliations

From the Department of Pediatrics, University of Southern California School of Medicine, and the Division of Rheumatology and Rehabilitation, Childrens Hospital of Los Angeles.


Footnotes

Read in part before the annual scientific meeting of the American Rheumatism Association, a Section of the Arthritis Foundation, New Orleans, June 1975.

Reprint requests to PO Box 54700, Los Angeles, CA 90054 (Dr Bernstein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Scientific Uncertainties in the Studies of Salicylate Use and Reye's Syndrome
Daniels et al.
JAMA 1983;249:1311-1316.
ABSTRACT  

Aspirin as a Risk Factor in Reye's Syndrome
Waldman et al.
JAMA 1982;247:3089-3094.
ABSTRACT  

Effects of Aspirin and Acetaminophen on the Liver
Zimmerman
Arch Intern Med 1981;141:333-342.
ABSTRACT  

Salicylate Therapy in Juvenile Rheumatoid Arthritis: Dose, Serum Level, and Toxicity
Doughty et al.
Arch Pediatr Adolesc Med 1980;134:461-463.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.